FTV IV, L.P.

CIK 1560793 · last filed 2023-06-16

FTV IV, L.P. is a corporate insider who has filed 2 SEC Form 4 insider transactions across 1 company since 2022. The most recent filing shows the insider was granted $18.6M of ENFN on Jun 16, 2023. Across all open-market trades the lifetime net is −$129.6M, making them a net seller over the disclosed history. The firm reports its address in San Francisco, CA. 4 SEC filings were submitted jointly with Bradford E Bernstein.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

1

Total Filings

2

Lifetime Open-Market Net

-$129.56M

Filer Profile

Reported Address

555 CALIFORNIA STREET, SUITE 2900
SAN FRANCISCO, CA 94104

Phone

(415) 229-3000

State of Incorporation

Related Filers

Bradford E Bernstein — 4 joint filings, latest 2025-04-21

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Enfusion, Inc. (ENFN) Delisted	Director	32,440,463	$10.76	$349.06M	-$129.56M	2	2023-06-16

Recent Filings

2 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2023-06-16	Enfusion, Inc. (ENFN) Delisted	Grant (A)	+2,285,714	$18.56M	EDGAR
2022-04-21	Enfusion, Inc. (ENFN) Delisted	Sell (S)	−8,151,062	-$129.56M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.